Peptide Industry News

FDA has run a coordinated enforcement sweep against peptide sellers marketing unapproved products, amid a wider Washington debate over acces...

A free evidence checker for peptide claims has launched as verification tools multiply across the research peptide market. What buyers shoul...

A new market intelligence index catalogs 100+ peptide vendors, 3,200+ listings and 112,000+ public COA records. How researchers can use it r...

Oral GLP-1 prescriptions keep climbing as the Wegovy pill and Lilly's oral tablet ramp up. What the tablet shift means for researchers and b...

Aggressive marketing, compounded copies, and purity concerns have put the GLP-1 weight-loss market under fire. Here is what researchers need...

FDA approves Eli Lilly's oral GLP-1 weight-loss pill, a needle-free option that reshapes obesity care, telehealth supply, and compounded GLP...

Semaglutide supply has recovered, ending the shortage that fueled compounded copies. The enforcement window is closing on gray-market GLP-1 ...

Retatrutide still has no FDA approval in 2026. What the Phase 3 TRIUMPH timeline means for researchers and why gray-market vials carry real ...

Third-party analytical testing for research peptides is scaling up as purity and mislabeling complaints grow. What stronger verification mea...

New data show GLP-1 prescriptions rising in children under 12 as semaglutide trial results reshape pediatric obesity care and safety scrutin...

China has approved semaglutide (Wegovy) as the first GLP-1 treatment for MASH liver disease, opening a new regulatory and research frontier....

Lawsuits linking Zepbound and Trulicity to NAION vision loss are mounting against Eli Lilly, raising fresh safety questions for the GLP-1 cl...

Moonwalk has raised $70M to move a fat-targeting RNAi obesity candidate into clinical development, adding a new mechanism to the obesity pip...

Novo Nordisk's IL-6 inhibitor failed two more cardiovascular outcome trials, a setback for inflammation-driven heart disease research beyond...

UK regulators froze over £200,000 in bank accounts and seized thousands of illicit GLP-1 doses in Operation Dunlin — what researchers need t...

Compounded semaglutide and tirzepatide have drawn more than 1,700 federal adverse event reports. We break down the FDA data and what it mean...

South Africa's High Court refused a compounding pharmacy's appeal in the semaglutide fight with Novo Nordisk, keeping the sales ban in force...

Medicine-safety monitors highlight researchers' blunt warning that clinical evidence for most consumer peptides is missing — how to grade pe...

Clinicians are raising safety concerns as peptide self-medication goes mainstream. Verification standards protect researchers as enforcement...

FDA is screening GLP-1 ingredients (semaglutide, tirzepatide) at U.S. borders and warns of vials labeled with pharmacies that do not exist. ...

Discover how peptide purity testing cost varies based on method, scope, and location. Learn to compare options for relia...

GLP-1 Cost Comparison: How to Get the Best Price Per Milligram. Price per mg across vendors (forum data: <$1/mg is good,...